Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group

PURPOSE: The effects of ovarian function suppression (OFS) on survival and patient-reported outcomes were evaluated in a phase III trial in which premenopausal women were randomly assigned to tamoxifen with or without OFS. PATIENTS AND METHODS: Premenopausal women with axillary node-negative, hormon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Tevaarwerk, Amye J., Wang, Molin, Zhao, Fengmin, Fetting, John H., Cella, David, Wagner, Lynne I., Martino, Silvana, Ingle, James N., Sparano, Joseph A., Solin, Lawrence J., Wood, William C., Robert, Nicholas J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4251958/
https://ncbi.nlm.nih.gov/pubmed/25349302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.55.6993
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados